A major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from Covid-19, bringing “important hope” to sufferers, the lead researcher said Sunday. Jean-Claude Tardif, head of the Montreal Heart Institute (ICM), led the study named “Colcorona,” whose preliminary results were published Friday evening. The complete results will be made public “as quickly as possible,” he said during an interview with AFP. Q: What are the main conclusions of your study, conducted on 4,488 patients throughout the world since March 2020? A: The Colcorona study provided convincing results of a more t
Hence then, the article about common anti inflammatory drug colchicine reduces covid 19 complications and deaths study was published today ( ) and is available onsamanews ( palestine ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Common anti-inflammatory drug colchicine reduces COVID-19 complications and deaths: study )